- Home
- PMEC vs CLDI Comparison
PMEC vs CLDI Comparison
Compare PMEC & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- CLDI
- Stock Information
- Founded
- PMEC 1984
- CLDI 2014
- Country
- PMEC Singapore
- CLDI United States
- Employees
- PMEC N/A
- CLDI N/A
- Industry
- PMEC
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMEC
- CLDI Health Care
- Exchange
- PMEC Nasdaq
- CLDI Nasdaq
- Market Cap
- PMEC 26.2M
- CLDI 22.3M
- IPO Year
- PMEC 2023
- CLDI N/A
- Fundamental
- Price
- PMEC $0.76
- CLDI $0.56
- Analyst Decision
- PMEC
- CLDI Strong Buy
- Analyst Count
- PMEC 0
- CLDI 2
- Target Price
- PMEC N/A
- CLDI $15.00
- AVG Volume (30 Days)
- PMEC 129.3K
- CLDI 433.2K
- Earning Date
- PMEC 12-31-2024
- CLDI 05-13-2025
- Dividend Yield
- PMEC N/A
- CLDI N/A
- EPS Growth
- PMEC N/A
- CLDI N/A
- EPS
- PMEC N/A
- CLDI N/A
- Revenue
- PMEC $74,310,000.00
- CLDI N/A
- Revenue This Year
- PMEC N/A
- CLDI N/A
- Revenue Next Year
- PMEC N/A
- CLDI N/A
- P/E Ratio
- PMEC N/A
- CLDI N/A
- Revenue Growth
- PMEC 5.07
- CLDI N/A
- 52 Week Low
- PMEC $0.49
- CLDI $0.54
- 52 Week High
- PMEC $1.13
- CLDI $8.30
- Technical
- Relative Strength Index (RSI)
- PMEC 48.52
- CLDI 30.41
- Support Level
- PMEC $0.74
- CLDI $0.66
- Resistance Level
- PMEC $0.79
- CLDI $0.79
- Average True Range (ATR)
- PMEC 0.04
- CLDI 0.06
- MACD
- PMEC -0.00
- CLDI -0.01
- Stochastic Oscillator
- PMEC 8.43
- CLDI 7.72
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.